DE69807115D1
Angiostatic agents and compositions for controlling ocular hypertension
Abstract
Compositions of angiostatic agents for treating GLC1A glaucoma and methods for their use are disclosed.
Term
Term ended
Expired 7 December 2018, 7.8 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
106 members in 15 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 99411497 | United States of America | A | |
| 99411497 | United States of America | A | |
| 9825913 | United States of America | W | |
| 9825913 | United States of America | W | |
| 994114 | – | – | – |
| PCTUS9825913 | – | – | – |
| US19970994114 | – | – | – |
| WO1998US25913 | – | – | – |
Members106
| Document | Office | Kind | |
|---|---|---|---|
| US4876250A | United States of America | A | |
| DK542989D0 | Denmark | D0 | |
| CA2001936A1 | Canada | A1 | |
| DK542989A | Denmark | A | |
| AU4370289A | Australia | A | |
| KR900005984A | Republic of Korea | A | |
| PT92123A | Portugal | A | |
| EP0371617A2 | European Patent Office (EPO) | A2 | |
| US4945089A | United States of America | A | |
| JPH02196722A | Japan | A | |
| CA2064478A1 | Canada | A1 | |
| WO9103245A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6295290A | Australia | A | |
| NZ231086A | New Zealand | A | |
| EP0371617A3 | European Patent Office (EPO) | A3 | |
| EP0489779A1 | European Patent Office (EPO) | A1 | |
| AU628874B2 | Australia | B2 | |
| EP0489779A4 | European Patent Office (EPO) | A4 | |
| JPH05500054A | Japan | A | |
| CA2123405A1 | Canada | A1 | |
| CA2425841A1 | Canada | A1 | |
| CA2425846A1 | Canada | A1 | |
| CA2425849A1 | Canada | A1 | |
| WO9310141A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU637824B2 | Australia | B2 | |
| AU3223593A | Australia | A | |
| WO9310141A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0371617B1 | European Patent Office (EPO) | B1 | |
| AT106731T | Austria | T | |
| ATE106731T1 | Austria | T1 | |
| DE68915958D1 | Germany | D1 | |
| EP0614463A1 | European Patent Office (EPO) | A1 | |
| DE68915958T2 | Germany | T2 | |
| US5371078A | United States of America | A | |
| JPH07501081A | Japan | A | |
| US5407926A | United States of America | A | |
| PT92123B | Portugal | B | |
| AU678961B2 | Australia | B2 | |
| DK172058B1 | Denmark | B1 | |
| US5679666A | United States of America | A | |
| US5698545A | United States of America | A | |
| EP0489779B1 | European Patent Office (EPO) | B1 | |
| AT162719T | Austria | T | |
| ATE162719T1 | Austria | T1 | |
| DE69032012D1 | Germany | D1 | |
| DE69032012T2 | Germany | T2 | |
| US5770592A | United States of America | A | |
| CA2296558A1 | Canada | A1 | |
| WO9903503A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8151598A | Australia | A | |
| CA2315829A1 | Canada | A1 | |
| WO9932127A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1714299A | Australia | A | |
| HK1012638A1 | Hong Kong, China | A1 | |
| US5990099A | United States of America | A | |
| CA2001936C | Canada | C | |
| EP1003553A1 | European Patent Office (EPO) | A1 | |
| JP3049504B2 | Japan | B2 | |
| EP1039912A1 | European Patent Office (EPO) | A1 | |
| BR9813684A | Brazil | A | |
| BR9811012A | Brazil | A | |
| HK1028952A1 | Hong Kong, China | A1 | |
| HK1029922A1 | Hong Kong, China | A1 | |
| AU734195B2 | Australia | B2 | |
| AU734436B2 | Australia | B2 | |
| JP2001510170A | Japan | A | |
| US6297228B1 | United States of America | B1 | |
| JP2001526233A | Japan | A | |
| CA2064478C | Canada | C | |
| EP1039912B1 | European Patent Office (EPO) | B1 | |
| AT221781T | Austria | T | |
| ATE221781T1 | Austria | T1 | |
| EP1236469A2 | European Patent Office (EPO) | A2 | |
| EP1236470A2 | European Patent Office (EPO) | A2 | |
| EP1236471A2 | European Patent Office (EPO) | A2 | |
| DE69807115D1This record | Germany | D1 | |
| DK1039912T3 | Denmark | T3 | |
| ES2177112T3 | Spain | T3 | |
| DE69807115T2 | Germany | T2 | |
| PT1039912E | Portugal | E | |
| HK1046369A1 | Hong Kong, China | A1 | |
| HK1046370A1 | Hong Kong, China | A1 | |
| HK1046371A1 | Hong Kong, China | A1 | |
| EP0614463B1 | European Patent Office (EPO) | B1 | |
| AT232540T | Austria | T | |
| ATE232540T1 | Austria | T1 | |
| JP3378245B2 | Japan | B2 | |
| DE69232925D1 | Germany | D1 | |
| DK0614463T3 | Denmark | T3 | |
| ES2187503T3 | Spain | T3 | |
| DE69232925T2 | Germany | T2 | |
| EP1003553B1 | European Patent Office (EPO) | B1 | |
| EP1236469A3 | European Patent Office (EPO) | A3 | |
| EP1236470A3 | European Patent Office (EPO) | A3 | |
| AT274356T | Austria | T | |
| ATE274356T1 | Austria | T1 | |
| DK1003553T3 | Denmark | T3 | |
| DE69825906D1 | Germany | D1 | |
| PT1003553E | Portugal | E | |
| EP1236471A3 | European Patent Office (EPO) | A3 |
Showing 100 of 106
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| No opposition during term of oppositionOpposition8364 | 8364 |
Numbers
- Publication, DOCDB
- 69807115
- Publication, EPODOC
- DE69807115D
- Application
- 69807115
- Application, DOCDB
- 69807115
- Application, EPODOC
- DE19986007115T
Titles2
- German
- ANGIOSTATISCHE VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG DES GLC1A GLAUKOMS
- English
- ANGIOSTATIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF GLC1A GLAUCOMA
Classification
- CPC, 17
- A61K31/573
- A61K31/00
- A61K31/56
- A61K31/565
- A61K31/569
- A61K31/57
- A61K31/58
- A61K31/665
- C07J3/00
- C07J5/0053
- C07J9/00
- C07J11/00
- C07J41/0005
- C07J41/0027
- C07J51/00
- A61P27/06
- A61P43/00
- IPC, 19
- A61K45 00
- A61K31 00
- A61K31 56
- A61K31 565
- A61K31 57
- A61K31 573
- A61K31 58
- A61K31 665
- A61P27 06
- A61P43 00
- C07J1 00
- C07J3 00
- C07J5 00
- C07J9 00
- C07J11 00
- C07J13 00
- C07J31 00
- C07J41 00
- C07J51 00